Abstract: A prism sheet, a curved backlight source and a display device are disclosed. The prism sheet includes a substrate and a plurality of prism units arranged on the substrate in an array. Each of the prism units has a triangular cross-section which has a first base angle and a second base angle, and both the first base angle and the second base angle are at a side of the cross-section close to the substrate. The degrees of the first and second base angles of the triangular cross-section of at least one of the plurality of prism units are different from each other. By means of the prism sheet, the backlight source and the display device according to the embodiments of the present invention, the uniformity of brightness of the emitted light may be improved, the visual angle may be increased, and as a result, the visual effect may be improved.

Abstract: The present invention relates to aminotetraline and aminoindane derivatives of the formula (I) or a physiologically tolerated salt thereof. The invention relates to pharmaceutical compositions comprising such aminotetraline and aminoindane derivatives, and the use of such aminotetraline and aminoindane derivatives for therapeutic purposes. The aminotetraline and aminoindane derivatives are GlyT1 inhibitors.

Abstract: The present invention relates to aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives of the formula (I) or a physiologically tolerated salt thereof. The invention relates to pharmaceutical compositions comprising such aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, and the use of such aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquin oline derivatives for therapeutic purposes. The aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives are GlyT1 inhibitors.

Abstract: The present invention provides a backlight and a display device. The backlight includes a frame and an optical film set including a plurality of optical films that are successively stacked. Each optical film in the optical film set includes a film body and an ear part. In any two adjacent optical films, the boundary of at least one side of the ear part of the lower optical film extends beyond the boundary of the same side of the ear part of the upper optical film. A fixing member covers the ear parts of the plurality of optical films, such that the optical film set is fixed on the frame, and the fixing member can fix the relative positions among the plurality of optical films in the optical film set. In the backlight, the optical film set is reliably fixed without affecting the normal display on the display device.

Abstract: The present invention relates to aminotetraline and aminoindane derivatives of the formula (I) or a physiologically tolerated salt thereof. The invention relates to pharmaceutical compositions comprising such aminotetraline and aminoindane derivatives, and the use of such aminotetraline and aminoindane derivatives for therapeutic purposes. The aminotetraline and aminoindane derivatives are GlyT1 inhibitors.

Abstract: The present invention relates to aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives of the formula (I) or a physiologically tolerated salt thereof. The invention relates to pharmaceutical compositions comprising such aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, and the use of such aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives for therapeutic purposes. The aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives are GlyT1 inhibitors.

Abstract: The present invention relates to 4,5-dihydropyrazole derivatives of the formula (I) and physiologically tolerated salts thereof which are GlyT1 inhibitors. The invention further relates to pharmaceutical compositions comprising such 4,5-dihydropyrazole derivatives, and the use of such 4,5-dihydropyrazole derivatives for therapeutic purposes.

Abstract: The present disclosure discloses a method, a device, and a system for displaying media data, which belong to the field of information processing technologies. The method includes: determining at least one piece of media data corresponding to a data display position; acquiring predicted click information and predicted display information corresponding to each piece of media data; and selecting one piece of media data from all the media data according to the predicted click information and the predicted display information corresponding to each piece of media data and displaying the selected media data on the data display position.

Abstract: A method for allocating an information display amount includes: determining an estimated display amount of unallocated information according to a total original display amount of all information display units and a displayed amount of allocated information; acquiring a predetermined display amount of the unallocated information according to the estimated display amount of the unallocated information; and allocating information displayed by each information display unit and a display amount according to the predetermined display amount of the unallocated information and a remaining display amount of the allocated information.

Abstract: A method and a system for processing network media information are provided. The method includes: collecting historical distribution effect data of network media information; performing attribute improvement processing on the historical distribution effect data by using population attribute data and network media information management data to obtain characteristic attribute data; constructing an effect parameter estimation model corresponding to each attribute of the characteristic attribute data, and training the effect parameter estimation model; estimating an effect parameter value of each audience for target network media information according to the effect parameter estimation model; and selecting an audience whose estimated effect parameter value is greater than or equal to a specified threshold value to form an audience population package to be extracted.

Abstract: A packaging structure and a packing method for a display panel are provided, the display panel includes a display panel body (201) and a circuit board (202), and the packaging structure of the display panel includes: a box body (301) including an inner chamber and an opening at an upper surface of the box body (301); and at least one support division plate (302) provided in the inner chamber of the box body. The support division plate (302) is configured to be perpendicular to the upper surface of the box body (301) and to divide the inner chamber of the box body (301) into a plurality of vertical placement spaces, so that each of the placement spaces is configured for the display panel (20) to be vertically placed therein with a display surface of the display panel body (201) placed in the placement space being perpendicular to the upper surface (w) of the box body.

Abstract: A detecting device for light-emitting property of a light source is provided and the detecting device for light-emitting property of a light source includes: a positioning device configured for fixing the light source; and a detection apparatus configured for acquiring a parameter of an emergent light from the light source. The detecting device for light-emitting property of a light source can detect the light-emitting property of the light source, thus help to select the chrominance and brightness degree, of a light source, required by a display module, and shorten the researching and manufacturing period for a liquid crystal display.

Abstract: The present application relates to aryl- and heteroaryl-fused decahydropyrroloazepine, octahydrooxepinopyrrole, octahydropyrrolothiazepine dioxide, decahydrocyclohepta[c]pyrrole, and octahydrocyclohepta[c]pyrrole derivatives of formula (I) wherein R1, R2, R3, R4, R5, A, Y1, Y2, and Y3 are as defined in the specification. The present application also relates to compositions comprising such compounds, processes for making such compounds, and methods of treating disease conditions using such compounds and compositions, and methods for identifying such compounds.

Abstract: The present invention relates to 4,5-dihydropyrazole derivatives of the formula (I) and physiologically tolerated salts thereof which are GlyT1 inhibitors. The invention further relates to pharmaceutical compositions comprising such 4,5-dihydropyrazole derivatives, and the use of such 4,5-dihydropyrazole derivatives for therapeutic purposes.

Abstract: The present invention provides a touch system and a display device, belongs to the technical field of display, and can solve the problem that misoperation is caused as an existing touch screen has a narrow frame and the edge area of the screen is easy to touch mistakenly. The touch system comprises a touch screen, a touch position analysis unit and a switch unit, wherein the touch screen comprises a center touch area and an edge touch area, and the touch position analysis unit is used for analyzing a position of a touch on the touch screen; and the switch unit is used for controlling whether a touch on the edge touch area is effective.

Abstract: The present invention provides a backlight and a display device. The backlight includes a frame and an optical film set including a plurality of optical films that are successively stacked. Each optical film in the optical film set includes a film body and an ear part. In any two adjacent optical films, the boundary of at least one side of the ear part of the lower optical film extends beyond the boundary of the same side of the ear part of the upper optical film. A fixing member covers the ear parts of the plurality of optical films, such that the optical film set is fixed on the frame, and the fixing member can fix the relative positions among the plurality of optical films in the optical film set. In the backlight, the optical film set is reliably fixed without affecting the normal display on the display device.

Abstract: The present invention discloses a display device with multiple display surfaces, including: a multi-surface display structure including at least two display panels; a light source provided under the middle part of the display structure; and a reflective surface including at least two reflectors having inclination angles is arranged on the top of the multi-surface display structure. The light source is provided under the multi-surface display structure, such that the bottom space of the display device is efficiently utilized, and the light shadow is eliminated. Therefore, the display performance is improved. The curved reflective surface provided on the top of the multi-surface display structure can reflect the light emitted from the light source, such that the light emergent from each display panel is uniform. The light energy is efficiently utilized (i.e., the utilization of the light source is increased). Thus, the purpose of energy-saving is achieved.

Abstract: The present application relates to aryl- and heteroaryl-fused decahydropyrroloazepine, octahydrooxepinopyrrole, octahydropyrrolothiazepine dioxide, decahydrocyclohepta[c]pyrrole, and octahydrocyclohepta[c]pyrrole derivatives of formula (I) wherein R1, R2, R3, R4, R5, A, Y1, Y2, and Y3 are as defined in the specification. The present application also relates to compositions comprising such compounds, processes for making such compounds, and methods of treating disease conditions using such compounds and compositions, and methods for identifying such compounds.

Abstract: A dimming unit, a backlight module group and a display device are disclosed in the disclosure. The dimming unit according to the disclosure includes a dimming body and a light source, a groove is provided on the dimming body, a cavity is provided on a first sidewall of the groove for accommodating the light source, and the cavity has a light outlet facing a second sidewall of the groove which is opposite to the first sidewall, so that a light ray is reflected by the second sidewall towards an opening of the groove. A backlight module group includes an optical film layer and a light source device provided on a side of a light incident surface of the optical film layer, the light source device includes the dimming unit according to the disclosure, and a light ray emitted by the dimming unit is emitted to the optical film layer.

Abstract: The present invention relates to aminotetraline and aminoindane derivatives of the formula (I) or a physiologically tolerated salt thereof. The invention relates to pharmaceutical compositions comprising such aminotetraline and aminoindane derivatives, and the use of such aminotetraline and aminoindane derivatives for therapeutic purposes. The aminotetraline and aminoindane derivatives are GlyT1 inhibitors.